Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Landos Biopharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Landos Biopharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mayleben Timothy M | Director | – | May 23, 2024 | 0 |
| Girao Tiago | Director | – | May 23, 2024 | 0 |
| Adsett Roger | Director | – | May 23, 2024 | 0 |
| Oakes Gregory | Chief Executive Officer | – | May 23, 2024 | 0 |
| Callori Fred | Director | – | May 23, 2024 | 0 |
| Garabedian Christopher Nishan | Director | – | May 23, 2024 | 0 |
| Cataldi Fabio | Chief Medical Officer | – | May 23, 2024 | 0 |
| Batycky Alka | Director | – | May 23, 2024 | 0 |
| Bassaganya-Riera Josep | 10% Owner | 0Indirect | Mar 2, 2023 | 0 |
| Truesdell Patrick | Vice President and Controller | – | Mar 2, 2023 | 0 |
| Edelman Joseph | 10% Owner | – | Jan 11, 2023 | 0 |
| Perceptive Advisors LLC | 10% Owner | – | Jan 11, 2023 | 0 |
| Perceptive Life Sciences Master Fund Ltd | 10% Owner | – | Jan 11, 2023 | 0 |
| Perceptive Xontogeny Venture Fund, LP | 10% Owner | – | Jan 11, 2023 | 0 |
| Perceptive Xontogeny Venture Fund II, LP | 10% Owner | – | Jan 11, 2023 | 0 |
| RTW Investments, LP | 10% Owner | 3,975,722Indirect | Sep 27, 2022 | 0 |
| Wong Roderick | 10% Owner | 3,975,722Indirect | Sep 27, 2022 | 0 |
| Bitar Patricia L | Interim CFO | – | Dec 21, 2021 | 0 |
| Chauhan Jyoti | ED, Global Clinical Operations | 209,299 | Nov 18, 2021 | 0 |
| Xontogeny, LLC | Director | – | Aug 31, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 (view filing) | Nov 29-30 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −50.4K | $7.22 | −$364.1K | −0.7%7.39M after | 2 lots |
| Dec 3, 2021 (view filing) | Dec 1-3 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −98.1K | $6.52 | −$640.0K | −1.3%7.30M after | 3 lots |
| Dec 8, 2021 (view filing) | Dec 6-8 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −103.5K | $6.45 | −$668.3K | −1.9%5.32M after | 3 lots |
| Dec 10, 2021 (view filing) | Dec 9-10 | 1 day | Bassaganya-Riera Josep10% Owner | SSale | −51.2K | $5.88 | −$300.7K | −1.0%5.27M after | 2 lots |
| Dec 15, 2021 (view filing) | Dec 13-15 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −125.0K | $5.16 | −$644.9K | −2.4%5.15M after | 3 lots |
| Dec 20, 2021 (view filing) | Dec 16-20 | 4 days | Bassaganya-Riera Josep10% Owner | SSale | −93.5K | $4.88 | −$456.1K | −1.8%4.99M after | 3 lots |
| Sep 27, 2022 (view filing)4:30 PM ET | Sep 23 | 4 days | RTW Investments, LP and 1 other10% Owner | SSale | −300.0K | $0.69 | −$207.0K | −7.0%3.98M after | |
| Jan 11, 2023 (view filing)6:45 PM ET | Jan 10 | 1 day | Edelman Joseph and 4 others10% Owner | PPurchase | +30.9M | $0.54 | +$16.7M | –3.64M after | Derivative2 lots |
| Mar 2, 2023 (view filing) | Feb 28 | 2 days | Bassaganya-Riera Josep10% Owner | SSale | −5.72M | – | – | −100.0%0 after | 5 lots |